It has been shown that both METTL3 and METTL14 contribute to the development and tumorigenesis of human glioma stem cells (GSCs), and METTL3 overexpression or suppression of FTO inhibits GSC self-renewal and growth (20). The gene discussed is METTL3; the disease is central nervous system cancer.